Profound Medical Sees Q3 Sales $9.800M-$10.000M vs $6.934M Est

Benzinga · 1d ago
Profound Medical (NASDAQ:PROF) sees Q3 sales of $9.800 million-$10.000 million vs $6.934 million analyst estimate.